Mylan Laboratories Limited

Vijaya Krishna Ravi

Vipin Kumar Kaushik

Srinivas Vakiti

Ramakoteswara Rao Jetti

Anjaneyaraju Indukuri

Sureshbabu Jayachandra

Rama Shankar

Hemant Malhari Mande

Saidugari Swamy

Dasari Srinivasa Rao

Seshadri Rao Manukonda

Subramanyam Dandala

Vadali Lakshmana Rao

Vikas Chandra Dev

Palla Vijay Kumar

Saiprasad Kottolla

Srinivasa Rao Potla

Mittapelly Nagaraju

Potla Venkata Srinivasa Rao

Jaldu Ravikanth

Ravi Venkata Naga Vikas Chandra Dev

Dandala Ramesh

Chaitanya Muggu

Narasimha Murty Pilli

Bhavanisankar Tirumalaraju

The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.

Polymorphic forms of sofosbuvir

A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein. 

Process for the preparation of sofosbuvir

The present disclosure relates to processes for the preparation of sofosbuvir or of its pharmaceutically acceptable salts. The present disclosure also provides intermediates useful in the synthesis of sofosbuvir.

The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation of Aliskiren.

Synthesis of Aliskiren

Growing community of inventors

Hyderabad Telangana, India

Vijaya Krishna Ravi